SOX17 and idiopathic pulmonary arterial hypertension: Expansion of the number of PAH-CHD patients assessed and characterization of the clinical phenotypes will be important to confirm the role of SOX17 in PAH-CHD and IPAH, and more precisely estimate the contribution of genes regulated by SOX17 and de novo mutations.